The Role of CD4+ T Cell Subsets in the Mechanism of Action of Vedolizumab in Ulcerative Colitis
Clinical trial NCT02721719 · UNKNOWN
Trial details
- NCT number
- NCT02721719
- Sponsor
- University of British Columbia
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2016-05-01
- Primary completion
- 2023-12-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.